KNAW
Narcis
Back to search results
Person
Prof.dr. P.C. Huijgens
Pagina-navigatie:
Main
Current research (5)
Completed research (10)
Update Persondata
cell
clinical
hematology
hemostasis
stem
thrombosis
transplantation
Expertise
Clinical hematology; Hemostasis; Thrombosis; Stem cell transplantation
Expertise (NL)
Klinische hematologie; Hemostase; Trombose; Stamceltransplantatie
Addition
hoogleraar / directeur CCA/V-ICI
Active as
Professor
Organisation
Department of Hematology (VU)
Chair (EN)
Hematology
Chair (NL)
Hematologie
Phone
+31-20-4442604
Email
pc. huijgens -at- vumc. nl
URL
http://www.hematologie.nl
Management
Organisation
VUmc Institute for Cancer and Immunology - CCA/V-ICI (VU)
Current research
(the most recent research is at the top)
Project leader
Pharmacokinetic and pharmacodynamic drug modelling in special patient populations, focus on oncology and immunology
Project leader
Response monitoring in non-Hodgkins lymphoma using Positron Emission Tomography
Project leader
90-Yttrium - Ibritumomab Tiuxetan (Zevalin®) and concurrent monitoring with 89-Zirconium-N-sucDf Ibritumomab tiuxetan for PET scanning
Researcher
Fish oil and GvHD
Project leader
Biosynthesis and function of base J, a new base in the nuclear DNA of kinetoplastid parasites
Completed research projects
(the most recent research is at the top)
Researcher
Targeted therapy in hematological malignancies: Antibody-targeting, erythropoietin and granulocyte-colony stimulating factor, farnesyl protein transferase and tyrosine kinase inhibitors.
Researcher
Response monitoring in non-Hodgkin's lymphoma using Positron Emission Tomography
Project leader
Clinical radioimmunotherapy with Rhenium-186-labeled monoclonal antibodies
Supervisor
The nature of primitive clonogenic AML cells and the role in emergence of minimal residual disease in AML
Project leader
A multicenter, phase III, open-label, randomized study in patients with advanced follicular lymphoma evaluating the benefit of maintenance therapy with Rituximab (MabThera®) after induction of response with chemotherapy plus Rituximab in comparison with no maintenance therapy
All completed research..
Classification
D23221
Blood and lymphatic diseases
Go to Website Navigation:
Home
about narcis
Nederlands
Royal Netherlands Academy of Arts and Sciences
Go to page top
Go back to contents
Go back to site navigation